DE:6DW Stock Latest News
Company AnnouncementsD. Western Therapeutics Outlines Q2 FY12/26 Results and Outlook2M ago
Company AnnouncementsD.Western Therapeutics Posts Deeper Losses, Keeps 2026 Outlook Unchanged2M ago
Company AnnouncementsDWTI’s Bondlido Gains U.S. Sales Partner as Launch Plans Advance5M ago
Company AnnouncementsD.Western Therapeutics Posts Deeper Quarterly Loss and Cuts 2026 Sales Outlook5M ago
Company AnnouncementsD. Western Therapeutics Completes Global Phase III Follow-Up for Fuchs Drug K-3217M ago
Company AnnouncementsD.Western Therapeutics Narrows Loss but Warns of Deeper Red Ink in 20268M agoCompany AnnouncementsD.Western Therapeutics Narrows Losses but Forecasts Deeper Red Ink in 20268M ago
Company AnnouncementsD. Western Therapeutics Institute Outlines FY2025 Results and FY2026 Outlook8M ago
Company AnnouncementsDWTI’s Glaucoma Combination Eye Drop GLA-ALPHA Debuts in Singapore Through Kowa9M ago
Company AnnouncementsD. Western Therapeutics Expands Global Reach with New Ophthalmic Solution in Malaysia10M ago
Company AnnouncementsD. Western Therapeutics Completes Observation Phase for K-321 Study11M ago
Company AnnouncementsD.Western Therapeutics Advances to Phase III Trial for Regenerative Eye Treatment11M agoCompany AnnouncementsD. Western Therapeutics Institute Reports Breakthrough in Dry Eye Treatment Research1y ago
Company AnnouncementsD. Western Therapeutics Gains FDA Approval for Bondlido Patch1y ago
Company AnnouncementsFDA Conditionally Approves New Name for D.Western’s Lidocaine Patch1y ago
Company AnnouncementsD.Western Therapeutics Institute Reports Decline in H1 2025 Financials1y ago
Company AnnouncementsD. Western Therapeutics Institute Unveils New Pipeline for Ocular Diseases1y ago
Company AnnouncementsD. Western Therapeutics Expands Glaucoma Treatment to Thailand1y agoCompany AnnouncementsD.Western Therapeutics Partners with Chordia for Ophthalmic Drug Development1y ago

